EXCLUSIVE: Adial Pharmaceuticals' Lead Drug Secures Key US Patent For Alcohol Dependence Based on Expanded Genotype Combinations [Yahoo! Finance]
Adial Pharmaceuticals, Inc (ADIL)
US:NASDAQ Investor Relations:
adialpharma.com
Company Research
Source: Yahoo! Finance
the company's intellectual property coverage for its lead investigational new drug product, AD04, used for the treatment of alcohol use disorder (AUD). (Source: Adial Pharmaceuticals announcement) The patent covers a broader range of genotype combinations identified by the company's proprietary genetic diagnostic for targeted treatment of AUD with AD04, including the HTR3A, HTR3B, and SLC6A4 receptor sites. This new patent strengthens the company's strategy to protect AD04 for treating AUD by covering all genotype combinations identified in its clinical program, ensuring intellectual property protection through 2031. (Source: Adial Pharmaceuticals announcement) The results showed that AD04 0.33mg delivered lower ondansetron PK exposure than the marketed reference standard ondansetron 4mg tablet; ondansetron pharmacokinetic exposure increased in proportion to dose across a 3–fold AD04 dose range; and AD04 could be taken in fed or fasted states. (Source: Adial Pharmaceuticals announ
Show less
Read more
Impact Snapshot
Event Time:
ADIL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ADIL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ADIL alerts
High impacting Adial Pharmaceuticals, Inc news events
Weekly update
A roundup of the hottest topics
ADIL
News
- Adial Pharmaceuticals Announces a Warrant Inducement Transaction for Approximately $2.86 Million in Gross Proceeds [Yahoo! Finance]Yahoo! Finance
- Adial Pharmaceuticals Announces a Warrant Inducement Transaction for Approximately $2.86 Million in Gross ProceedsGlobeNewswire
- Adial Pharmaceuticals GAAP EPS of -$0.08 [Seeking Alpha]Seeking Alpha
- Adial Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update [Yahoo! Finance]Yahoo! Finance
- Adial Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business UpdateGlobeNewswire
ADIL
Sec Filings
- 12/23/25 - Form PRE
- 12/19/25 - Form 424B5
- 12/18/25 - Form EFFECT
- ADIL's page on the SEC website